Italian Serial Acquirers: Only 2 of 11 Earn Above Cost of Capital
[Part of our Global Serial Acquirer Scorecard]
Key Finding: Only 2 of 11 Italian serial acquirers earn above 12% ROIC. Six companies — 55% of the screen — cluster in the 5-10% band. Italy has the highest Tier C concentration of any market we screen. The average GW/TA of 21% is the lowest of any market, yet 82% still earn below cost of capital. Disciplined pricing per deal does not guarantee disciplined returns.
We screened 11 Italian serial acquirers listed on Borsa Italiana by return on invested capital. Two earn above a 12% cost of equity. One sits at the borderline. Six cluster in Tier C — earning between 5% and 10%. Two destroy value outright. Italy’s problem is not overpaying for acquisitions. It is the inability to convert moderate balance sheets into adequate returns.
The Italian Serial Acquirer Scorecard
| # | Company | Ticker | ROIC | GW/TA | (GW+Int)/TA | Op Margin | Drawdown | Tier | Verdict |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Recordati | REC | 22.6% | 16% | 19% | 28.2% | -37.1% | A | Best in class. CVC-owned. Declining from 30%. |
| 2 | Reply | REY | 15.3% | 26% | 30% | 16.2% | -54.9% | A | Decade of 15%+ ROIC. Most consistent Italian. |
| 3 | Carel Industries | CRL | 10.5% | 29% | 16% | 11.5% | -44.2% | B | Collapsed from 19%. Last deal doubled goodwill. |
| 4 | DiaSorin | DIA | 8.7% | 26% | 60% | 22.4% | -70.4% | C | Was 27% ROIC. Luminex destroyed it. |
| 5 | Interpump | IP | 8.4% | 25% | 19% | 16.1% | -60.9% | C | Was 14%. Cyclical + acquisition drag. |
| 6 | Brembo | BRE | 7.9% | 2% | 26% | 10.3% | -50.5% | C | Mainly organic. Low GW/TA, still below CoC. |
| 7 | SeSa | SES | 6.4% | 0% | 2% | 2.6% | -69.2% | C | Zero goodwill (data issue?). Margins too thin. |
| 8 | Amplifon | AMP | 5.5% | 49% | 70% | 10.5% | -71.9% | C | Never earned CoC. GW approaching 50%. |
| 9 | MARR | MARR | 5.4% | 14% | 79% | 4.1% | -56.2% | C | Was 17%. COVID wrecked HoReCa distribution. |
| 10 | Datalogic | DAL | 2.6% | 28% | 13% | 0.2% | -80.8% | D | Was 19%. Margins approaching zero. |
| 11 | Tinexta | TNXT | 2.5% | 43% | 20% | 11.7% | -81.9% | D | Overpayer. GW/TA > 40%, classic pattern. |
Tier A: 2 companies (18%). Tier B: 1 (9%). Tier C: 6 (55%). Tier D: 2 (18%).
82% earn below a 12% cost of equity. Italy’s defining feature is the Tier C cluster — not bonfires, but six companies stuck in the 5-10% band where capital earns less than it costs but not enough less to force action.
Two That Work — With Different Models
Recordati — 22.6% ROIC with 16% GW/TA and 19% (GW+Int)/TA. The highest ROIC in the Italian screen and one of the highest across all 14 markets. Operating margins of 28.2% reflect a specialty pharma franchise with pricing power. CVC Capital Partners took Recordati private, then relisted. The caveat: ROIC has declined from 30%. CVC ownership adds governance risk — private equity exits typically prioritize cash extraction over long-term compounding. Down 37.1%.
Reply — 15.3% ROIC with 26% GW/TA and 30% (GW+Int)/TA. Italy’s only genuinely consistent serial acquirer. ROIC has stayed between 15-18% for a decade. Family-controlled by the Rizzante family. Reply buys small IT consulting firms, integrates tightly, and cross-sells across technology verticals. Operating margins of 16.2% are healthy for a services business. GW/TA of 26% is manageable. Down 54.9% from peak — priced alongside companies earning 5% ROIC. The market is treating Reply like the rest of Italy’s mediocre acquirers. The numbers say otherwise.
The Borderline: Carel Industries
Carel Industries — 10.5% ROIC with 29% GW/TA and 16% (GW+Int)/TA. Collapsed from 19% ROIC. The last deal doubled goodwill. Operating margins of 11.5% are thin for a company carrying 29% GW/TA. Down 44.2%. Carel is the test case: if the Kiona acquisition integrates and ROIC recovers toward 15%, this is a mispriced compounder. If it doesn’t, Carel joins the Tier C cluster permanently.
The Tier C Swamp
Six Italian serial acquirers earn between 5% and 10% ROIC. No other market concentrates this heavily in the uncomfortable middle. Germany is binary — Tier A or Tier D. Italy sits in the band where returns are insufficient but not catastrophic enough to force restructuring.
The Fallen Giants
DiaSorin and Interpump both earned well above cost of capital before acquisition drag pulled them down. DiaSorin was a 27% ROIC diagnostic franchise with 12% GW/TA and 37% margins. One $1.8 billion Luminex acquisition cut ROIC by two-thirds to 8.7%, pushed GW/TA to 26%, and sent the stock down 70.4%. Interpump fell from 14% ROIC as cyclicality and acquisition drag combined. Both are former Tier A companies living in Tier C.
Never Earned Cost of Capital
Amplifon — 5.5% ROIC with 49% GW/TA and 70% (GW+Int)/TA. The world’s largest hearing aid retailer with ~12,000 shops across 26 countries. Revenue compounded from EUR 465 million to EUR 2.4 billion over 20 years. ROIC has never exceeded 10%. Every acquisition adds customers and goodwill in equal measure. Operating margins of 10.5% cannot service a 49% goodwill load. Scale without capital efficiency. Down 71.9%.
SeSa — 6.4% ROIC with 0% GW/TA and 2% (GW+Int)/TA. QuickFS reports zero goodwill across all years despite numerous acquisitions — a data quality issue. Regardless: 2.6% operating margins on a distribution business do not pass the screen. Down 69.2%.
COVID Casualty
MARR — 5.4% ROIC with 14% GW/TA and 79% (GW+Int)/TA. Was 17% ROIC before COVID devastated its HoReCa distribution business. Never recovered. Operating margins of 4.1% are too thin to service the intangible base. Down 56.2%.
Organic but Insufficient
Brembo — 7.9% ROIC with 2% GW/TA and 26% (GW+Int)/TA. Primarily an organic grower — the lowest goodwill in the screen. Included for completeness but not a typical serial acquirer. Even without acquisition drag, Brembo earns below cost of capital. Operating margins of 10.3% on a capital-intensive brake manufacturing business cannot generate adequate returns. Low GW/TA does not save you if the underlying business is capital-heavy. Down 50.5%.
The Value Destroyers
Datalogic — 2.6% ROIC with 28% GW/TA and 13% (GW+Int)/TA. Was 19% ROIC. Secular decline in barcode scanning collapsed margins to 0.2% — effectively zero. Down 80.8%.
Tinexta — 2.5% ROIC with 43% GW/TA and 20% (GW+Int)/TA. The classic overpayer pattern: GW/TA above 40%, ROIC below 5%. Operating margins of 11.7% are decent, but the goodwill load is too heavy. Down 81.9% — the deepest drawdown in the Italian screen.
The Standout: Reply
Reply is the company worth studying. In a market where 82% of serial acquirers earn below cost of capital, Reply has maintained 15%+ ROIC for a decade.
The model is distinctive. Reply acquires small, specialized IT consulting firms — typically 50-200 people — and integrates them into a networked structure where each unit retains its identity but gains access to cross-selling across Reply’s technology verticals. Family control (the Rizzante family) prevents the empire-building impulse that destroys most serial acquirers. GW/TA at 26% stays manageable because the targets are small and priced reasonably.
The result: 15.3% ROIC, 16.2% operating margins, and a decade of consistency. The stock is down 54.9% from peak. That drawdown prices Reply like a Tier C name earning 5-8% ROIC — a mispricing if the decade-long track record holds.
The Cautionary Tale: DiaSorin’s Luminex Disaster
DiaSorin is the Italian version of a pattern we see in every market: one deal destroys a decade of compounding.
Pre-Luminex (2021): 27% ROIC, 12% GW/TA, 37% operating margins. A world-class diagnostic franchise earning returns that placed it among the best serial acquirers globally. Post-Luminex: 8.7% ROIC, 26% GW/TA, 22.4% operating margins. The $1.8 billion acquisition doubled the goodwill base and compressed operating margins from 37% to 22.4%. The stock fell 70.4%.
DiaSorin’s underlying franchise remains intact. The diagnostic business still generates strong cash flows. But the Luminex goodwill sits in the denominator permanently, and the acquired business has not delivered the margins needed to service the premium paid. One deal turned a Tier A compounder into a Tier C laggard.
Cross-Market Context
| Metric | Italy (11) | Germany (10) | Sweden (24) | UK (11) |
|---|---|---|---|---|
| Above 12% ROIC | 2 (18%) | 3 (30%) | 6 (25%) | 2 (18%) |
| Below 5% ROIC | 2 (18%) | 6 (60%) | 9 (38%) | 3 (27%) |
| Avg GW/TA | 21% | 27% | 34% | 28% |
| Avg Op Margin | 11.2% | 10.2% | 8.8% | 12.3% |
| Worst drawdown | -81.9% TNXT | -63.3% BKHT | -61.8% VIT-B | -50.2% JDG |
Italy has the lowest average GW/TA (21%) of any market we screen. Italian acquirers pay less per deal relative to their balance sheets than Swedish acquirers (34%) or German ones (27%). Yet Italy’s Tier A rate (18%) is no better than the UK’s, and worse than Germany’s 30%.
The Tier C concentration tells the story. Germany is binary — 30% Tier A, 60% Tier D. Spain matches the US at 38% Tier A but also has 38% Tier D — equally polarized. Italy clusters in the middle: 55% Tier C. Italian serial acquirers are disciplined enough to avoid catastrophic overpayment but not disciplined enough to earn above cost of capital. Moderate goodwill, moderate margins, inadequate returns.
What to Look For in Italian Serial Acquirers
Four filters for this market:
- Demand a decade of consistency. Reply’s 15%+ ROIC over ten years is the standard. Italy’s fallen giants — DiaSorin, Interpump, MARR — all had peak ROICs above 14% that collapsed. A single year above cost of capital means nothing in a market where regression is the norm.
- Watch the combined intangible ratio. GW/TA alone understates balance sheet risk. DiaSorin’s 26% GW/TA becomes 60% at (GW+Int)/TA. Amplifon’s 49% becomes 70%. MARR’s 14% becomes 79%. The true acquisition load hides in identifiable intangibles.
- Low goodwill is not enough. Brembo at 2% GW/TA and 7.9% ROIC proves that organic growers in capital-intensive industries can still earn below cost of capital. Capital efficiency requires both disciplined pricing and high-margin businesses.
- Beware the one-deal destroyer. DiaSorin lost two-thirds of its ROIC from a single acquisition. Carel Industries doubled goodwill in one deal and fell from 19% to 10.5%. In Italy, the biggest risk is not chronic overpaying — it is one transformative deal that loads the balance sheet and compresses returns permanently.
Methodology
We screened 11 Italian serial acquirers listed on Borsa Italiana (Milan). All financial data in EUR.
- ROIC: Net operating profit after tax / invested capital (equity + debt - cash), with goodwill included in the denominator. Source: QuickFS (latest fiscal year, exchange code: BIT).
- GW/TA: Goodwill / total assets (most recent quarter). Source: QuickFS.
- (GW+Int)/TA: Combined goodwill and identifiable intangible assets / total assets. Source: QuickFS.
- Operating margin: Operating income / revenue (latest fiscal year). Source: QuickFS.
- Drawdown: Maximum decline from 5-year peak. Source: Yahoo Finance (.MI suffix).
- Tier classification: A (>12%), B (10-12%), C (5-10%), D (<5%).
- Data as of: February 2026.
Brembo (BRE) is primarily organic (2% GW/TA); included for completeness but not a typical serial acquirer. SeSa (SES) shows zero goodwill across all years in QuickFS — likely a data quality issue. Reply (REY) operating margin data has anomalous values in 2010-2015 (possible QuickFS reporting format change); recent years are clean.
Research basis: Mauboussin & Callahan (2023) found that 41% of bottom-quintile ROIC companies remain stuck after three years. Italy’s Tier C cluster — six companies earning 5-10% — fits this pattern. Companies in the uncomfortable middle rarely climb out. The 55% Tier C concentration is not a temporary dip; it reflects structural capital allocation that generates insufficient returns without triggering the restructuring that might fix them.